Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 971712, 15 pages
http://dx.doi.org/10.1155/2013/971712
Research Article

P90RSK and Nrf2 Activation via MEK1/2-ERK1/2 Pathways Mediated by Notoginsenoside R2 to Prevent 6-Hydroxydopamine-Induced Apoptotic Death in SH-SY5Y Cells

Key Laboratory of Bioactive Substances and Resources Utilization of Chinese Herbal Medicine, Ministry of Education, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 151, Malianwa North Road, Haidian District, Beijing 100193, China

Received 17 June 2013; Revised 27 July 2013; Accepted 12 August 2013

Academic Editor: Paul Siu-Po Ip

Copyright © 2013 Xiang-Bao Meng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Xiang-Bao Meng, Gui-Bo Sun, Min Wang, Jing Sun, Meng Qin, and Xiao-Bo Sun, “P90RSK and Nrf2 Activation via MEK1/2-ERK1/2 Pathways Mediated by Notoginsenoside R2 to Prevent 6-Hydroxydopamine-Induced Apoptotic Death in SH-SY5Y Cells,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 971712, 15 pages, 2013. https://doi.org/10.1155/2013/971712.